Key Insights for CAH Investors – What You Should Know Today

By Harris Dyer • Friday, August 22 15:32 • Permanent Link

Large-cap Health Care company Cardinal Health has moved -2.6% so far today on a volume of 1,585,804, compared to its average of 2,240,185. In contrast, the S&P 500 index moved 2.0%.

Cardinal Health trades -18.22% away from its average analyst target price of $180.46 per share. The 13 analysts following the stock have set target prices ranging from $150.0 to $203.0, and on average have given Cardinal Health a rating of buy.

Anyone interested in buying CAH should be aware of the facts below:

Cardinal Health has moved 38.5% over the last year, and the S&P 500 logged a change of 13.1%
Based on its trailing earnings per share of 6.46, Cardinal Health has a trailing 12 month Price to Earnings (P/E) ratio of 22.8 while the S&P 500 average is 29.3
CAH has a forward P/E ratio of 17.1 based on its forward 12 month price to earnings (EPS) of $8.64 per share
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally.
Based in Dublin, the company has 53,084 full time employees and a market cap of $35.24 Billion. Cardinal Health currently returns an annual dividend yield of 1.3%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.